Annual Shareholders Equity
$6.64 M
+$5.28 M+387.31%
31 December 2023
Summary:
Titan Pharmaceuticals annual stockholders equity is currently $6.64 million, with the most recent change of +$5.28 million (+387.31%) on 31 December 2023. During the last 3 years, it has risen by +$1.50 million (+29.27%). TTNP annual shareholders equity is now -94.21% below its all-time high of $114.74 million, reached on 31 December 2000.TTNP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$3.99 M
-$2.09 M-34.38%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly stockholders equity is currently $3.99 million, with the most recent change of -$2.09 million (-34.38%) on 30 June 2024. Over the past year, it has dropped by -$2.65 million (-39.87%). TTNP quarterly shareholders equity is now -96.52% below its all-time high of $114.74 million, reached on 31 December 2000.TTNP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -39.9% |
3 y3 years | +29.3% | -22.3% |
5 y5 years | +363.5% | +178.7% |
TTNP Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +387.3% | -50.9% | +486.3% |
5 y | 5 years | -2.8% | +387.3% | -60.0% | +250.2% |
alltime | all time | -94.2% | +128.7% | -96.5% | +114.7% |
Titan Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $3.99 M(-34.4%) |
Mar 2024 | - | $6.09 M(-8.4%) |
Dec 2023 | $6.64 M(+387.3%) | $6.64 M(-18.3%) |
Sept 2023 | - | $8.13 M(-886.6%) |
June 2023 | - | -$1.03 M(+231.4%) |
Mar 2023 | - | -$312.00 K(-122.9%) |
Dec 2022 | $1.36 M(-73.5%) | $1.36 M(-61.6%) |
Sept 2022 | - | $3.55 M(-37.4%) |
June 2022 | - | $5.67 M(-28.1%) |
Mar 2022 | - | $7.88 M(+53.4%) |
Dec 2021 | $5.14 M(+45.5%) | $5.14 M(-31.5%) |
Sept 2021 | - | $7.50 M(-14.3%) |
June 2021 | - | $8.75 M(-12.4%) |
Mar 2021 | - | $9.98 M(+182.6%) |
Dec 2020 | $3.53 M(+146.5%) | $3.53 M(-493.8%) |
Sept 2020 | - | -$897.00 K(-157.5%) |
June 2020 | - | $1.56 M(-70.4%) |
Mar 2020 | - | $5.28 M(+268.2%) |
Dec 2019 | $1.43 M(-79.0%) | $1.43 M(-153.9%) |
Sept 2019 | - | -$2.66 M(+365.8%) |
June 2019 | - | -$571.00 K(-118.7%) |
Mar 2019 | - | $3.06 M(-55.3%) |
Dec 2018 | $6.83 M(+697.1%) | $6.83 M(+24.4%) |
Sept 2018 | - | $5.49 M(-518.1%) |
June 2018 | - | -$1.31 M(+55.2%) |
Mar 2018 | - | -$846.00 K(-198.7%) |
Dec 2017 | $857.00 K(-93.5%) | $857.00 K(-78.8%) |
Sept 2017 | - | $4.04 M(-46.4%) |
June 2017 | - | $7.54 M(-28.9%) |
Mar 2017 | - | $10.61 M(-19.6%) |
Dec 2016 | $13.19 M(+88.7%) | $13.19 M(-13.6%) |
Sept 2016 | - | $15.26 M(-13.7%) |
June 2016 | - | $17.68 M(+222.9%) |
Mar 2016 | - | $5.48 M(-21.7%) |
Dec 2015 | $6.99 M(-18.8%) | $6.99 M(-21.6%) |
Sept 2015 | - | $8.92 M(+349.0%) |
June 2015 | - | $1.99 M(-52.6%) |
Mar 2015 | - | $4.19 M(-51.3%) |
Dec 2014 | $8.61 M(+49.5%) | $8.61 M(+102.6%) |
Sept 2014 | - | $4.25 M(+22.8%) |
June 2014 | - | $3.46 M(-19.1%) |
Mar 2014 | - | $4.28 M(-25.7%) |
Dec 2013 | $5.76 M(-124.9%) | $5.76 M(+463.6%) |
Sept 2013 | - | $1.02 M(-52.4%) |
June 2013 | - | $2.15 M(-170.4%) |
Mar 2013 | - | -$3.05 M(-86.8%) |
Dec 2012 | -$23.13 M(+15.2%) | -$23.13 M(-14.8%) |
Sept 2012 | - | -$27.13 M(+18.0%) |
June 2012 | - | -$23.00 M(-2.9%) |
Mar 2012 | - | -$23.69 M(+18.0%) |
Dec 2011 | -$20.08 M(+231.7%) | -$20.08 M(+14.4%) |
Sept 2011 | - | -$17.55 M(+3.3%) |
June 2011 | - | -$16.98 M(+62.9%) |
Mar 2011 | - | -$10.43 M(+72.2%) |
Dec 2010 | -$6.05 M | -$6.05 M(+78.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | -$3.39 M(+0.1%) |
June 2010 | - | -$3.39 M(+109.7%) |
Mar 2010 | - | -$1.62 M(+11.6%) |
Dec 2009 | -$1.45 M(-105.7%) | -$1.45 M(-118.8%) |
Sept 2008 | - | $7.70 M(-41.6%) |
June 2008 | - | $13.18 M(-34.4%) |
Mar 2008 | - | $20.10 M(-20.7%) |
Dec 2007 | $25.35 M(+143.6%) | $25.35 M(+146.9%) |
Sept 2007 | - | $10.27 M(-27.6%) |
June 2007 | - | $14.19 M(+95.8%) |
Mar 2007 | - | $7.25 M(-30.3%) |
Dec 2006 | $10.40 M(-32.3%) | $10.40 M(-22.2%) |
Sept 2006 | - | $13.37 M(-23.4%) |
June 2006 | - | $17.45 M(-15.7%) |
Mar 2006 | - | $20.70 M(+34.8%) |
Dec 2005 | $15.36 M(-54.4%) | $15.36 M(-0.7%) |
Sept 2005 | - | $15.47 M(-29.1%) |
June 2005 | - | $21.83 M(-20.4%) |
Mar 2005 | - | $27.43 M(-18.6%) |
Dec 2004 | $33.71 M(-24.1%) | $33.71 M(-17.8%) |
Sept 2004 | - | $41.02 M(-12.8%) |
June 2004 | - | $47.06 M(-10.7%) |
Mar 2004 | - | $52.72 M(+18.7%) |
Dec 2003 | $44.43 M(-37.2%) | $44.43 M(-13.4%) |
Sept 2003 | - | $51.30 M(-10.8%) |
June 2003 | - | $57.50 M(-10.3%) |
Mar 2003 | - | $64.12 M(-9.4%) |
Dec 2002 | $70.74 M(-29.3%) | $70.74 M(-10.9%) |
Sept 2002 | - | $79.38 M(-8.7%) |
June 2002 | - | $86.92 M(-7.7%) |
Mar 2002 | - | $94.17 M(-6.0%) |
Dec 2001 | $100.13 M(-12.7%) | $100.13 M(-6.2%) |
Sept 2001 | - | $106.73 M(-3.3%) |
June 2001 | - | $110.32 M(-1.5%) |
Mar 2001 | - | $112.00 M(-2.4%) |
Dec 2000 | $114.74 M(+159.0%) | $114.74 M(+50.2%) |
Sept 2000 | - | $76.41 M(-5.3%) |
June 2000 | - | $80.69 M(-2.0%) |
Mar 2000 | - | $82.36 M(+85.9%) |
Dec 1999 | $44.30 M(+371.3%) | $44.30 M(+506.8%) |
Sept 1999 | - | $7.30 M(-23.2%) |
June 1999 | - | $9.50 M(-24.6%) |
Mar 1999 | - | $12.60 M(+34.0%) |
Dec 1998 | $9.40 M(-45.3%) | $9.40 M(-25.4%) |
Sept 1998 | - | $12.60 M(-17.6%) |
June 1998 | - | $15.30 M(-12.1%) |
Mar 1998 | - | $17.40 M(+1.2%) |
Dec 1997 | $17.20 M(+50.9%) | $17.20 M(-1533.3%) |
Sept 1997 | - | -$1.20 M(-146.2%) |
June 1997 | - | $2.60 M(-252.9%) |
Mar 1997 | - | -$1.70 M(-114.9%) |
Dec 1996 | $11.40 M(-296.6%) | $11.40 M(-24.5%) |
Sept 1996 | - | $15.10 M(+277.5%) |
June 1996 | - | $4.00 M(-37.5%) |
Mar 1996 | - | $6.40 M(-210.3%) |
Dec 1995 | -$5.80 M | -$5.80 M |
FAQ
- What is Titan Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Titan Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of TTNP is $6.64 M
What is the all time high annual shareholders equity for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual stockholders equity is $114.74 M
What is Titan Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of TTNP is $3.99 M
What is the all time high quarterly shareholders equity for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly stockholders equity is $114.74 M
What is Titan Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, TTNP quarterly stockholders equity has changed by -$2.65 M (-39.87%)